0001519749-20-000005.txt : 20200925
0001519749-20-000005.hdr.sgml : 20200925
20200925121703
ACCESSION NUMBER: 0001519749-20-000005
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200924
FILED AS OF DATE: 20200925
DATE AS OF CHANGE: 20200925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hart Jayne B.
CENTRAL INDEX KEY: 0001519749
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 201198133
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
3
1
edgardoc.xml
PRIMARY DOCUMENT
X0206
3
2020-09-24
0
0000899923
MYRIAD GENETICS INC
MYGN
0001519749
Hart Jayne B.
320 WAKARA WAY
SALT LAKE CITY
UT
84108
0
1
0
0
Executive VP Human Resources
Common Stock
57267
D
Incentive Stock Option (right to buy)
23.98
2022-03-07
Common Stock
3500
D
Incentive Stock Option (right to buy)
24.89
2021-05-25
Common Stock
8034
D
Incentive Stock Option (right to buy)
26.49
2021-09-17
Common Stock
3775
D
Incentive Stock Option (right to buy)
27.07
2022-09-12
Common Stock
593
D
Non-Qualified Stock Option (right to buy)
19.47
2021-09-13
Common Stock
28000
D
Non-Qualified Stock Option (right to buy)
23.98
2022-03-07
Common Stock
7000
D
Non-Qualified Stock Option (right to buy)
24.89
2021-05-25
Common Stock
21966
D
Non-Qualified Stock Option (right to buy)
26.49
2021-09-17
Common Stock
73225
D
Non-Qualified Stock Option (right to buy)
27.07
2022-09-12
Common Stock
51907
D
The combined Incentive Stock Option and Non-Qualified Stock Option grants vest and become exercisable 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
By: Nathan A. Smith For: Jayne B. Hart
2020-09-25
EX-24
2
powerofattorneyhart.txt
EDGAR SUPPORTING DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned
hereby constitutes and appoints each of
Benjamin G. Jackson, R. Bryan Riggsbee and
Nathan A. Smith of Myriad Genetics, Inc.
the Company, and Jonathan L. Kravetz,
and Daniel Follansbee of Mintz, Levin, Cohn,
Ferris, Glovsky and Popeo, P.C., signing
singly, with full power of substitution, the
undersigned's true and lawful attorney-in-fact to:
1 execute for and on behalf of the
undersigned, forms and authentication
documents for EDGAR Filing Access;
2 do and perform any and all acts
for and on behalf of the undersigned which
may be necessary or desirable to
complete and execute any such forms
and authentication documents;
3 execute for and on behalf of
the undersigned, in the undersigned's
capacity as an officer, director and/or
10% shareholder of the Company, Forms 3, 4 and 5
in accordance with Section 16a of
the Securities Exchange Act of 1934
and the rules thereunder;
4 do and perform any and all acts
for and on behalf of the undersigned
which may be necessary or desirable
to complete and execute any such
Form 3, 4 or 5 and timely
file such form with the United States
Securities and Exchange Commission and
any stock exchange or similar authority; and
5 take any other action of any type
whatsoever in connection with the foregoing
which, in the opinion of such attorney-in-fact,
may be of benefit to, in the best interest
of, or legally required by, the undersigned,
it being understood that the documents executed by
such attorney-in-fact, on behalf of the
undersigned pursuant to this Power of Attorney,
shall be in such form and shall contain
such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such
attorney-in-fact full power and authority to
do and perform any and every act and thing
whatsoever requisite, necessary, or proper
to be done in the exercise of any of the
rights and powers herein granted, as fully
to all intents and purposes as the undersigned
might or could do if personally present,
with full power of substitution or revocation,
hereby ratifying and confirming all that
such attorney-in-fact, or such
attorney-in-facts substitute or substitutes,
shall lawfully do or cause to be done by
virtue of this power of attorney and the
rights and powers herein granted.
The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving
in such capacity at the request of the
undersigned, is not assuming, nor is the
Company assuming, any of the undersigneds
responsibilities to comply with Section 16
of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in
full force and effect until the undersigned
is no longer required to file Forms 3, 4
and 5 with respect to the undersigned's
holdings of and transactions in securities
issued by the Company, unless earlier revoked
by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned
has caused this Power of Attorney to
be executed this 21st day of September, 2020.
/S/ Jayne Hart
Jayne Hart